Skip to main content
Explore URMC

URMC Logo

menu
URMC / Research Alliances / Previous Events
 

Previous Events

YNC with STO
August 2-3, 2017, DARPA Conference Center, Arlington, VA
The Defense Advanced Research Projects Agency (DARPA) Strategic Technology Office (STO) event will familiarize attendees with STO's vision, problem spaces, program managers, and technology interests.  Attendees will explore innovative and solution ideas for strategic national security challenges. 

GUIRR Webinar: Gender in the Global Research Landscape
Thursday, July 20, 2017; 1:00-2:00 p.m. EDT. 
Learn about the recent report released on research performance through a gender lens which spans 20 years, 12 geographies and 27 disciplines. 

Find a Research Topic Fit: USDA and NSF SBIR Programs
Tuesday, July 25, 2017; 1:00-3:30 p.m. EDT
This webinar will guide entrepreneurs and researchers through searching research topics within the Small Business Innovation Research (SBIR) program.  SBIR offers federal funding for research and development projects that meet specific agency needs.  Participants learn about these research topics and how to compete for funding from both agencies. 

PDA/FDA Biosimilars Conference, June 26-27, 2017, Hyatt Regency Bethesda, MD
This conference brings together industry experts and regulators to discuss latest advancements and strategies required to bring biosimilars to market.  Contact Andrea Chamblee with any questions.

AHR Conference 2016 - The aryl hydrocarbon Receptor as a Central Mediator of Health and Disease, August 3-6, 2016, Rochester, NY. 

FDA Webinars: July 27, 2016
“Next Generation Sequencing Draft Guidances: Technical and Regulatory Aspects,” will focus on the technical and regulatory aspects of the guidances.

“Next Generation Sequencing (NGS) Draft Guidances: Implications for Patients and Providers,” will address the significance of those guidances for patients and health care providers.

GUIRR Webinar - Thursday, July 21, 2016, 1-2:30 PM ET
I-Corps at the National Institutes of Health presented by representatives from the National Cancer Institute SBIR Development Center.